Your browser doesn't support javascript.
loading
Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.
Jardim, Denis L F; Tang, Chad; Gagliato, Debora De Melo; Falchook, Gerald S; Hess, Kenneth; Janku, Filip; Fu, Siqing; Wheler, Jennifer J; Zinner, Ralph G; Naing, Aung; Tsimberidou, Apostolia M; Holla, Vijaykumar; Li, Marylin M; Roy-Chowdhuri, Sinchita; Luthra, Raja; Salgia, Ravi; Kurzrock, Razelle; Meric-Bernstam, Funda; Hong, David S.
Afiliação
  • Jardim DL; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gagliato Dde M; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Falchook GS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hess K; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wheler JJ; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zinner RG; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Holla V; Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li MM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Roy-Chowdhuri S; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Luthra R; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Salgia R; University of Chicago, Chicago, Texas.
  • Kurzrock R; Department of Medicine, University of California, San Diego, La Jolla, California.
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas. dshong@mdanderson.org.
Clin Cancer Res ; 20(24): 6336-45, 2014 Dec 15.
Article em En | MEDLINE | ID: mdl-25326232
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amplificação de Genes / Proteínas Proto-Oncogênicas c-met / Neoplasias Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Cancer Res Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amplificação de Genes / Proteínas Proto-Oncogênicas c-met / Neoplasias Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Clin Cancer Res Ano de publicação: 2014 Tipo de documento: Article